Nebenwirkungen · CellCept
CellCept 1 g/5 ml powder for oral suspension · Abschnitt 4.8 · PDF-Seite 59
HOS-085374 · Präparat HOS-083095
System Organ Class Infections and infestations Very common Very common Very common (48.5%) (44.1%) (51.5%) Blood and lymphatic system disorders Leukopenia Very common Very common Very common (30.3%) (29.4%) (12.1%) Anaemia Very common Very common Very common (51.5%) (32.4%) (27.3%) Gastrointestinal disorders Diarrhoea Very common Very common Very common (87.9%) (67.6%) (30.3%) Vomitting Very common Very common Very common (69.7%) (44.1%) (36.4%)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-07T14:22:00Z · SHA-256 8464b0a5294445d85b3f9b902633989ca6f57af3990241a80eda4979936ba419 · Passage 1540f6a24d27b6480416323526e3ecd7fdb09bbbd4ba8a5749464f41c2d1976a · Zeichen 17408–18442 im Abschnitt